Status: Not yet recruiting
Clinical Experience With Sparsentan in Switzerland in IgA Nephropathy
An observational study tracking the clinical course of patients with IgA nephropathy.
Participants needed: 50
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Waid City Hospital, ZurichUpdated: Apr 29, 2026Locations: 1
Eligibility criteria
IgA Nephropathy, Use of Sparsentan
age < 18y